Aarti Drugs Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
AARTIDRUGS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aarti Drugs has informed the exchanges that its trading window will be closed from January 1, 2026 until 48 hours after the company declares its financial results for the quarter and nine months ended December 31, 2025. This is a routine compliance measure mandated under SEBI's Prohibition of Insider Trading Regulations, 2015. During this period, designated persons and their immediate relatives are restricted from trading in the company's shares.
This is a standard regulatory notice with no direct impact on shareholders or stock price. However, it signals that the company's Q3 FY26 earnings results are forthcoming, which investors should watch for as it may influence near-term price movement.